CD4-T-Lymphocyte Interactions with Pneumolysin and Pneumococci Suggest a Crucial Protective Role in the Host Response to Pneumococcal Infection

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2689-2697

  Kadioglu, Aras ^a   Coward, William ^a   Colston, M Joseph ^b   Hewitt, Colin R A ^a   Andrew, Peter W ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PNEUMOLYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; FEMALE; HOST; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REPRODUCIBILITY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; FEMALE; GENES, MHC CLASS II; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 2142763016     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2689-2697.2004     Document Type: Article

References (35)

1. Abrami, L., M. Fivaz, P. E. Glauser, R. G. Parton, and F. G. van der Goot. 1998. A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J. Cell Biol. 140:525-540.
2. Alexander, J. E., R. A. Lock, C. C. A. M. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansmann, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.
3. Benton, K. A., M. P. Everson, and D. E. Briles. 1995. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect. Immun. 63:448-455.
4. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.
5. Boulnois, G. J., J. C. Paton, T. J. Mitchell, and P. W. Andrew. 1991. Structure and function of pneumolysin, the multifunctional thiol-activated toxin of Streptococcus pneumoniae. Mol. Microbiol. 5:2611-2616.
6. Braun, J. S., R. Novak, G. Gao, P. J. Murray, and J. L. Shenep. 1999. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect. Immun. 67:3750-3756.
7. Canvin, J. R., A. P. Marvin, M. Sivakumaran, J. C. Paton., G. J. Boulnois, P. W. Andrew, and T. J. Mitchell. 1995. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 172:119-123.
8. Cockeran, R., C. Durandt, C. Feldman, T. J. Mitchell, and R. Anderson. 2002. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 186:562-565.
9. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051-1066.
10. Ejstrud, P., B. Kristensen, J. B. Hansen, K. M. Madsen, H. C. Schonheyder, and H. T. Sorensen. 2000. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand. J. Infect. Dis. 32:521-525.
11. Ferrante, A., B. Rowan-Kelly, and J. C. Paton. 1984. Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect. Immun. 46:585-589.
12. Gilbert, R. J. C., J. Rossjolin, M. W. Parker, R. K. Tweten, P. J. Morgan, T. J. Mitchell, N. Errington, A. J. Rowe, P. W. Andrew, and O. Byron. 1998. Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae. J. Mol. Biol. 284:1223-1237.
13. Gingles, N. A., J. E. Alexander, A. Kadioglu, P. W. Andrew, A. Kerr, T. J. Mitchell, E. Hopes, P. Denny, S. Brown, H. B. Jones, S. Little, G. C. Booth, and W. L. McPheat. 2001. The role of genetic resistance in invasive pneumococcal infection: identification and study of susceptible and resistant inbred mouse strains. Infect. Immun. 69:426-434.
14. Haraguchi, S., N. K. Day, R. P. Nelson, Jr., P. Emmanuell, J. E. Duplantier, C. S. Christodoulou, and R. A. Good. 1998. Interleukin 12 deficiency associated with recurrent infections. Proc. Natl. Acad. Sci. USA 95:13125-13129.
15. Hirst, R. A., H. Yesilkaya, E. Clitheroe, A. Rutman, N. Dufty, T. J. Mitchell, C. O'Callaghan, and P. W. Andrew. 2002. Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Infect. Immun. 70:1017-1022.
16. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect. Immun. 62:1501-1503.
17. Jounblat, R., A. Kadioglu, T. J. Mitchell, and P. W. Andrew. 2003. Pneumococcal behavior and host response during bronchopneumonia are affected by the cytolytic and complement-activating activitivs of pneumolysin. Infect. Immun. 71:1813-1819.
18. Kadioglu, A., N. Gingles, K. Grattan, T. J. Mitchell, and P. W. Andrew. 2000. The host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 2:492-501.
19. Kadioglu, A., S. Taylor, F. Iannelli, G. Pozzi, T. J. Mitchell, and P. W. Andrew. 2002. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect. Immun. 70:2886-2890.
20. Kanclerski, K., and R. Mollby. 1987. Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J. Clin. Microbiol. 25:222-225.
21. Kemp, K., H. Bruunsgaard, P. Skinhoj, and B. K. Pedersen. 2002. Pneumococcal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells. Infect. Immun. 70:5019-5025.
22. Lavelle, E. C., E. McNeela, M. E. Arrastrong, O. Leavy, S. C. Higgins, and K. H. G. Mills. 2003. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 171:2384-2392.
23. Lock, R. A., D. Hansman, and J. C. Paton. 1992. Comparative efficacy of autolysin and paeumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae. Microb. Pathog. 5:461-467.
24. Madden, J. C., N. Rulz, and M. Caparon. 2001. Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in Gram-positive bacteria. Cell 104:143-152.
25. Madsen, L., N. Labrecque, J. Engberg, A. Dierich, A. Svejgaard, C. Benoist, D. Mathis, and L. Fugger. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA 96:10338-10343.
26. McGuirk, P., and K. H. G. Mills. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23:450-455.
27. Ogunniyi, A. D., P. Giammarinaro, and J. C. Paton. 2002. The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology 148:2045-2053.
28. Paton, J. C., and A. Ferrante. 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41:1212-1216.
29. Rubins, J. B., and C. Pomeroy. 1997. Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect. Immun. 65: 2975-2977.
30. Shevach, E. M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
31. Tascon, R. E., E. Stavropoulos, K. V. Lukacs, and M. J. Colston. 1998. Protection against Mycobacterium tuberculosis infection by CD8 T cells requires the production of gamma interferon. Infect. Immun. 66:830-834.
32. Torres, J. M., O. Cardenos, A. Vasquez, and D. Schlossberg. 1998. Streptococcus pneumoniae bacteremia in a community hospital. Chest 113:387-390.
33. Tuomanen, E., R. Rich, and O. Zak. 1987. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am. Rev. Respir. Dis. 135:869-874.
34. Valeva, A., I. Walev, and S. Bhakdi. 2000. The nature of the high affinity-binding site for staphylococcal alpha toxin: introducing the concept of a quasi receptor. Med. Microbiol. Immunol. 189:51-55.
35. Waheed, A. A., Y. Shimada, H. F. G. Heijnen, M. Nakamura, M. Inomata, M. Hayashi, S. Iwashita, J. W. Slot, and Y. Ohno-Iwashita. 2001. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl. Acad. Sci. USA 98:4926-4931.